David A. Siegel Biomea Fusion, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 296,800 shares of BMEA stock, worth $474,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
296,800
Previous 491,000
39.55%
Holding current value
$474,880
Previous $1.05 Million
48.9%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.1MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.14 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.71 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.75 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.28 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.01 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $46.9M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...